For years, breast cancer treatment has been guided by genetic alterations found in tumor tissue, typically through invasive biopsies.

Olaparib plus abiraterone improved survival vs placebo in BRCA-mutated metastatic castration-resistant prostate cancer.

A local radio host is encouraging Tucsonans to consider genetic testing after it played a critical role in her own health ...

Researchers determined the clinical classification of more than 90% of potential BRCA2 variants of uncertain significance in ...

February is American Heart Month, which is an appropriate time to learn how genetic testing can protect your family.

Published in Cell Reports Medicine, results of a VHIO-led study support the feasibility of using RAD51 testing to complement ...

While genetic testing rates for advanced ovarian cancer have increased, gaps in physician understanding and confidence in interpreting results may limit optimal biomarker-driven treatment and patient ...

We also report on the attitudes towards predictive testing and counselling within these families ... the prior identification of a BRCA mutation in their own family, the mode of inheritance of such a ...

Cytogenetic tests evaluate whole chromosomes from the nucleus of the cell for changes in number or structure. Cytogenetic testing is often the first tier of genetic testing for a number of ...

was used as a validation Ethics approval is in place approved by the North Manchester Research Ethics Committee (reference 08/H1006/77), although the study reflects an audit of BRCA testing with no ...

Testing has increased tenfold over the past decade for mutations in the BRCA2 gene, which along with BRCA1 is considered a significant predictor of inherited breast cancer risks. Mutations in ...